Steven Cohen’s Pyxis Oncology PYXS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-37,092
Closed -$112K – 4439
2026
Q2
$112K Buy
37,092
+5,086
+16% +$9.7K ﹤0.01% 3679
2026
Q1
$46.7K Sell
32,006
-156,130
-83% -$235K ﹤0.01% 3664
2025
Q4
$216K Buy
+188,136
New +$664K ﹤0.01% 3610
2023
Q2
– Sell
-251,800
Closed -$1.01M – 2670
2023
Q1
$1.01M Buy
+251,800
New +$503K ﹤0.01% 1105

Other funds holding PYXS

Steven Cohen's PYXS Position: Q3 2026 in Review

Steven Cohen sold out of Pyxis Oncology (PYXS) in Q3 2026, closing a stake of 37,092 shares — an estimated $112K sold.

Steven Cohen first reported a position in PYXS in Q1 2023 and held it in 4 quarters. The position peaked at $1.01M in Q1 2023. 101 funds tracked by Wall St. Rank hold PYXS as of Q3 2026.

  • Steven Cohen reported no remaining Pyxis Oncology position as of Q3 2026 after selling out during the quarter.
  • Steven Cohen sold 37,092 Pyxis Oncology shares in Q3 2026, an estimated $112K.
  • Steven Cohen first reported a position in Pyxis Oncology in Q1 2023 and held it in 4 quarters.
  • Steven Cohen's Pyxis Oncology position peaked at $1.01M in Q1 2023.
  • 101 funds tracked by Wall St. Rank held Pyxis Oncology as of Q3 2026.

Based on Point72 Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.